Women and Lung Cancer Research and Preventive Services Act of 2025
Sponsored By: Senator Tina Smith
In Committee
Summary
Accelerating research on lung cancer in women and underserved populations. This bill would direct the Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, to lead an interagency review to identify research gaps, improve access to preventive services, and guide public awareness and education on lung cancer.
Show full summary
- Women and underserved populations: Would require a focused review of existing research and gaps, including study of environmental and genomic factors linked to lung cancer in women.
- Screening programs and patients: Would look for ways to increase lung cancer screening rates among groups the United States Preventive Services Task Force recommends for screening.
- Researchers and technology development: Would seek interagency and multidisciplinary research opportunities and promote advances such as biomarker testing to improve risk assessment, diagnosis, and treatment.
- Federal planning and barriers: Would deliver a report within 2 years summarizing findings, ongoing projects, recommended changes to federal programs or strategic plans, and statutory barriers to implementation.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Review lung cancer research for women
If enacted, HHS would lead an interagency review of federal lung cancer research and preventive services focused on women and underserved groups. HHS would consult with the Departments of Defense and Veterans Affairs. The review would identify research gaps, consider environmental and genomic studies, and look for ways to raise screening rates among groups the U.S. Preventive Services Task Force recommends. Not later than two years after enactment, HHS would send a report to specified House and Senate committees summarizing findings, current projects, recommended changes, and legal or statutory barriers.
Sponsors & CoSponsors
Sponsor
Tina Smith
MN • D
Cosponsors
Shelley Capito
WV • R
Sponsored 3/26/2025
Mazie Hirono
HI • D
Sponsored 1/8/2026
Susan Collins
ME • R
Sponsored 1/8/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in